Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sacubitril (AHU-377) 是一种有效的NEP 抑制剂,IC50=5 nM。它是研究心力衰竭药物 LCZ696 的组分之一。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 248 | 现货 | ||
5 mg | ¥ 578 | 现货 | ||
10 mg | ¥ 763 | 现货 | ||
25 mg | ¥ 1,170 | 现货 | ||
50 mg | ¥ 1,490 | 现货 | ||
100 mg | ¥ 2,390 | 现货 | ||
200 mg | ¥ 3,570 | 现货 | ||
500 mg | ¥ 5,680 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 638 | 现货 |
产品描述 | Sacubitril (AHU-377) is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril is a component of the heart failure medicine LCZ696. |
靶点活性 | NEP:5 nM |
体外活性 | LCZ696 is a single molecule that is comprised of molecular moieties of valsartan, an ARB, and AHU377, a neprilysin inhibitor (1:1 ratio). AHU377 is converted by enzymatic cleavage of the ethyl ester into the active neprilysin inhibiting metabolite LBQ657[2]. The inactive NEPi precursor, AHU377, does not inhibit collagen accumulation in fibroblasts nor cardiac myocyte hypertrophy. In cardiac fibroblasts, the active NEPi LBQ657 had no discernible effects. In contrast, LBQ657 modestly inhibits cardiac myocyte hypertrophy[3]. |
体内活性 | In humans, AHU377 (tmax?0.5-1.1 h) are absorbed quickly. AHU377 is converted rapidly into LBQ657 with its tmax?being reached in 1.9-3.5 h. Mean t1/2?values for the biologically active LBQ657 is 9.9-11.1 h[2].In vehicle-treated dogs, ANF increases urinary sodium excretion from 17.3±3.6 to 199.5±18.4 pequivkglmin. This effect is potentiated significantly in animals which receive AHU377. Urinary volume is also potentiated in animals which receive an iv administration of AHU377[1]. |
别名 | AHU 377, AHU377, 沙库必曲, AHU-377 |
分子量 | 411.49 |
分子式 | C24H29NO5 |
CAS No. | 149709-62-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (66.83 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.4302 mL | 12.151 mL | 24.3019 mL | 60.7548 mL |
5 mM | 0.486 mL | 2.4302 mL | 4.8604 mL | 12.151 mL | |
10 mM | 0.243 mL | 1.2151 mL | 2.4302 mL | 6.0755 mL | |
20 mM | 0.1215 mL | 0.6075 mL | 1.2151 mL | 3.0377 mL | |
50 mM | 0.0486 mL | 0.243 mL | 0.486 mL | 1.2151 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Sacubitril 149709-62-6 Metabolism Neprilysin Neutral endopeptidase AHU 377 inhibit NEP antihypertensive AHU377 natriuretic peptide 沙库必曲 AHU-377 Cluster of differentiation 10 Inhibitor COVID-19 CD10 heart failure inhibitor